Status:
COMPLETED
Remote 3-week Booster Intervention to Reduce Sedentary Time in Patients With Coronary Artey Disease
Lead Sponsor:
Radboud University Medical Center
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn about the effect of a booster program aiming to lower daily sitting time (SIT LESS Booster program) compared to usual care in patient with coronary heart pr...
Detailed Description
High levels of sedentary time (ST) are observed in patients with coronary artery disease (CAD) and are associated with adverse health outcomes. Behavioural interventions targeting ST are effective in ...
Eligibility Criteria
Inclusion
- • Participation in the SIT LESS intervention group of the SIT LESS study
Exclusion
- Unable to give informed consent
- Wheelchair-bounded / not physically able to stand or walk.
- Language barrier
- Coronary arterial bypass graft surgery expected within 8 weeks after inclusion
- New York Heart Association class III or IV heart failure
- Participation in another interventional study targeting SB or PA
Key Trial Info
Start Date :
August 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06038188
Start Date
August 30 2023
End Date
December 31 2023
Last Update
March 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6525GA